Suchergebnisse - "Andrikovics, Hajnalka"

PubPharm (135)

31

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)

enthalten in: Journal of cancer research and clinical oncology | 2019

von Möbius, S. | Schenk, T. | Himsel, D. | +17

32

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning

enthalten in: PloS one | 2019

von Tordai, A. | Bors, A. | Kiss, K. | +11

33

International external quality assurance of JAK2 V617F quantification

enthalten in: Annals of hematology | 2018

von Asp, J. | Skov, V. | Bellosillo, B. | +31

34

International external quality assurance of JAK2 V617F quantification

enthalten in: Annals of hematology | 2018

von Asp, J. | Skov, V. | Bellosillo, B. | +31

35

International external quality assurance of JAK2 V617F quantification

enthalten in: Annals of hematology | 2018

von Asp, J. | Skov, V. | Bellosillo, B. | +31

36

Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Dinya, T. | Tornai, T. | Vitalis, Z. | +9

37

Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression

enthalten in: Scientific reports | 2018

von Zámbó, B. | Bartos, Z. | Mózner, O. | +8

38

The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma

enthalten in: Leukemia & lymphoma | 2018

von Kiss, K. | Varga, G. | Mikala, G. | +11

39

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies

enthalten in: Human immunology | 2018

von Balassa, K. | Andrikovics, H. | Remenyi, P. | +12

40

Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2017

von Varga, G. | Mikala, G. | Kiss, K. | +11